[{"Assets_0_Q3_USD":234236000.0,"CommonStockSharesOutstanding_0_Q3_shares":32692000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-44175000.0,"NetIncomeLoss_1_Q3_USD":-7637000.0,"NetIncomeLoss_3_Q3_USD":-25339000.0,"StockholdersEquity_0_Q3_USD":103410000.0,"Ticker":"JNCE","CIK":"1640455","name":"JOUNCE THERAPEUTICS, INC.","OfficialName":"Jounce Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"354419760.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181113"}]